Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Clinical trial NCT04464564 · TERMINATED
Trial details
- NCT number
- NCT04464564
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2024-06-28
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.